FMO3 and Obesity: It was suggested that higher activity of the enzyme FMO3, which metabolizes TMA to TMAO, might cause the observed increase, since FMO3 is known to be upregulated in obese patients, and PsA, as well as Ps, is linked to obesity and metabolic syndrome.